Because these observations suggest that vitamin D deficiency may play a key role in the outcome of critically ill patients, we performed an 11-yr multicenter observational study of critically ill patients among whom 25(OH)D was measured within 1 yr before hospitalization. The aim of this study is to determine the relationship between preadmission 25(OH)D deficiency and mortality following ICU admission.
MATERIALS AND METHODS
Source Population. We extracted administrative and laboratory data from individuals admitted to two academic teaching hospitals in Boston, MA. Brigham and Women's Hospital is a 777-bed teaching hospital with 100 ICU beds. Massachusetts General Hospital is a 902bed teaching hospital with 109 ICU beds. The two hospitals provide primary as well as tertiary care to an ethnically and socioeconomically diverse population within eastern Massachusetts and the surrounding region.
Data Sources. Data on all patients admitted to Brigham and Women's Hospital or Massachusetts General Hospital between November 2, 1997 and April 1, 2009 were obtained through a computerized registry which serves as a central clinical data warehouse for all inpatients and outpatients seen at these hospitals. The database contains information on demographics, medications, laboratory values, microbiology data, procedures, and the records of inpatient and outpatients. Approval for the study was granted by the Institutional Review Board of Brigham and Women's Hospital and Massachusetts General Hospital. The Institutional Review Board waived the need for informed consent.
The following data were retrieved: demographics, vital status for up to 11 yrs following ICU admission, preadmission 25(OH)D measured between 7 and 365 days of hospital admission, year and season 25(OH)D was measured, microbiology data, latitude of patient address, hospital admission and discharge date, diagnosis-related group assigned at discharge, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes, and Current Procedural Terminology (CPT) codes for in-hospital procedures. The primary analyses examined the preadmission 25(OH)D in patients as the exposure of interest.
Study Population. During the 11-yr period of study, there were 54,392 unique patients, age Ն18 yrs, who were assigned the CPT code 99,291 (critical care, first 30 -74 mins). A total of 205 foreign patients without Social Security numbers were identified and excluded as vital status in this study is determined by the Social Security Death Index. We excluded 2,372 patients assigned CPT code 99,291 who received care only in the Emergency Room, were not admitted, and were not assigned a diagnosisrelated group. In patients with multiple ICU admissions, the first date of CPT code 99,291 assignment was used. A total of 51,815 patients constituted the total ICU population.
A total of 2439 patients in the total ICU population had 25(OH)D drawn 7-365 days before the first day of CPT code 99,291 assignment. A total of 36 of 2,435 patients who received vitamin D supplementation following the 25(OH)D level draw date were identified and excluded. A total of 2,399 patients constituted the study cohort.
Exposure of Interest and Comorbidities. The exposure of interest was preadmission 25(OH)D and categorized a priori as deficiency [25(OH)D level of Յ15 ng/mL], insufficiency [25(OH)D level of 16 -29 ng/mL], and sufficiency [25(OH)D level of Ն30 ng/ mL] (14) .
We utilized the Deyo-Charlson index to assess the burden of chronic illness (15) . The Deyo-Charlson index consists of 17 comorbidities, which are weighted and summed to produce a score, each with an associated weight based on the adjusted risk of 1-yr mortality. This score ranges from 0 to 33, with higher scores indicating a higher burden. The score does not measure type or severity of acute illness (15, 16) . We employed the International Classification of Diseases, Ninth Revision, coding algorithms developed by Quan et al (17) to derive a comorbidity score for each patient. The validity of the algorithms by Quan et al (17) for International Classification of Diseases, Ninth Revision, coding from administrative data are reported. Due to scant representation, Deyo-Charlson index scores of Ͼ8 were combined.
Patient type is defined as medical or surgical and incorporates the diagnosis-related group methodology, devised by the Centers for Medicare & Medicaid Services (18) .
Sepsis was defined by the presence of any of the following ICD-9-CM codes during hospitalization: 038.0 -038.9, 020.0, 790.7, 117.9, 112.5, 112.81 (19) . Acute myocardial infarction is defined by ICD-9-CM 410.0 -410.9 (20) assignment before or on the day of ICU admission. The number of organs with failure was adapted from Martin et al (19) and defined by a combination of ICD-9-CM and CPT codes relating to acute organ dysfunction assigned from 3 days before ICU admission to 30 days after ICU admission, as outlined in the online supplement (Supplemental Digital Content 1, http://links.lww.com/CCM/A214).
Procedures were determined by CPT codes as follows: coronary artery bypass graft surgery performed on the day prior or after ICU admission (CPT codes 33,510 -33,536), percutaneous coronary intervention including stents on the day prior to or after ICU admission (CPT codes 92,980 -92,984, 92,995, 92,996, 93,508, 93,510 -93,529, 93,539 -93,540, 93,543, and 93,545-93,552) (21), renal replacement therapy in the ICU (hemodialysis code, CPT 90,935; continuous renal replacement therapy code, CPT 90,945).
All patients who had blood cultures drawn 48 hrs prior or subsequent to an ICU admission were identified. Blood cultures were defined as positive if aerobic, anaerobic, or fungal blood cultures grew identifiable organisms.
Assessment of Mortality. Information on vital status for the study cohort was obtained from the Social Security Death Index. The Social Security Death Index yields a high sensitivity and specificity for classifying deaths (22, 23) . The censoring date was April 2, 2010.
End Points. The primary end point was 30-day mortality following ICU admission. Prespecified secondary end points included 90-day, 365-day, and in-hospital morality.
Statistical Analysis. Categorical covariates were described by frequency distribution and compared across vitamin D groups using contingency tables and chi-square testing. Continuous covariates were examined graphically (e.g., histogram, box plot) and in terms of summary statistics (mean, SD, median, interquartile range) and compared across exposure groups using one-way analysis of variance. The outcomes considered were death by days 30, 90, and 365 post-ICU admission, in-hospital mortality, and blood culture positivity.
Unadjusted associations between vitamin D groups and outcomes were estimated by the Mantel-Haenszel methods and by bivariable logistic regression analysis. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both vitamin D levels and mortality. For the primary model (30-day mortality), specification of each continuous covariate (as a linear vs. categorical term) was adjudicated by the empirical association with the primary outcome using Akaike's Information Criterion; the overall model fit was assessed using the Hosmer-Lemeshow test. Models for secondary analyses (90-day, 365-day, and in-hospital mortality) were specified identically to the primary model to bear greatest analogy. Sensitivity analyses were performed for patients with 25(OH)D measured Ͻ60 days (n ϭ 1011) or measured Ͻ90 days (n ϭ 1236) before hospital admission. All p values presented are twotailed; values below .05 were considered nominally significant. All analyses are performed using STATA 10.0MP (College Station, TX). Table 1 shows demographic characteristics of the study population. The majority of patients were women (57.2%), were white (80.3%), and had medical-related diagnosis-related groups (58.3%). A total of 41.7% of patients had surgical-related diagnosis-related groups. The mean age at ICU admission was 64.9 yrs (SD 16.6 yrs). The mean latitude was 42.2°north (SD 1.4°north). The mean 25(OH)D level was 26.4 ng/mL (SD 15.2 ng/mL). The majority of vitamin D measurements occurred 3 months before ICU admission (29.8% within 1 month, 51.6% within 3 months, and 73.3% within 6 months).
RESULTS
On the basis of ICD-9-CM code criteria, 287 patients were identified with acute myocardial infarction, 577 patients were identified with sepsis, and 143 patients had positive blood cultures. In the study cohort, procedures included coronary artery bypass graft surgery in nine patients, percutaneous coronary intervention in 19, and renal replacement therapy in 22. Due to scant representation, procedures were not further analyzed in the cohort.
The study cohort differs from the total ICU population in the period studied. In general, the study cohort is an older predominately female group with higher disease comorbidity, more sepsis by International Classification of Diseases, Ninth Revision, criteria, less organ failure, less blood culture positivity, and a higher mortality than the total ICU population ( Table 1) .
Patient characteristics of the study cohort were stratified according to preadmission 25(OH)D levels ( Table 2 ). Factors that significantly differed between stratified groups included age, race, season, sepsis, and number of organs with failure. Factors that did not significantly differ between stratified groups included gender, blood culture positivity, Deyo-Charlson index, latitude, neighborhood poverty, type (surgical vs. medical), and acute myocardial infarction. Due to overlap of International Classification of Diseases, Ninth Revision, codes with the Deyo-Charlson index, the number of organs with failure variable was not further analyzed in the cohort.
Primary Outcome. Preadmission 25(OH)D was a strong predictor of allcause mortality with a significant risk gradient across 25(OH)D groups ( Table  3 ). The risks of mortality 30 days following ICU admission were 1.3-and 1.7-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency. 25(OH)D in the cohort remains a significant predictor of risk of mortality following adjustment for age, sex, race, Deyo-Charlson index, season, type (surgical vs. medical), and sepsis. The adjusted risks of mortality were 1.4-and 1.7-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency ( Table 3) .
Secondary Outcomes. The risks of mortality 90 days following ICU admission were 1.4-and 1.6-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency. The multivariable adjusted risks of mortality were 1.5-and 1.7-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency ( Table 3 ).
The risks of mortality 365 days following ICU admission were 1.4-and 1.6-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency. The multivariable adjusted risks of mortality were 1.3-and 1.4-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency ( Table 3 ).
The risks of in-hospital mortality following ICU admission were 1.3-and 1.8-fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency. The multivariable adjusted risks of mortality were 1.3-and 1.7fold higher in patients with 25(OH)D values in the insufficient and deficient groups, respectively, compared with those with vitamin D sufficiency ( Table 3) .
The association between vitamin D and mortality was not materially modified with additional covariate adjustment for number of failed organs (data not shown). The association between vitamin D and mortality was not modified by the presence or absence of sepsis (p interaction: 30 day, .72; 90 day, .32; 365 day, .32; in-hospital, .84). The interaction tests suggest that the associations between 25(OH)D level and mortality are the same in septic patients as in nonseptic patients.
A sensitivity analysis was performed of the effects of excluding patients with pre- admission 25(OH)D levels obtained Ͼ90 days before admission. Following exclusion of such patients, the association between vitamin D and in-hospital, 30-day, 90-day, or 365-day mortality following critical care was not modified. Additionally, sensitivity analysis of the effects of excluding patients with preadmission 25(OH)D levels obtained Ͼ60 days before admission does not materially change the association between vitamin D and mortality (Table 4 ). In a subgroup analysis of patients who had blood cultures drawn (n ϭ 1160), preadmission 25(OH)D deficiency was associated with increased risk of blood culture positivity ( Table 5 ). The risk for blood culture positivity of mortality was 1.6-fold higher in patients with 25(OH)D values in the deficient group, compared with those with vitamin D sufficiency. The multivariable adjusted risk for blood culture positivity was 1.6-fold higher in patients with 25(OH)D values in the de-ficient group, compared with those with vitamin D sufficiency. Patients with 25(OH)D insufficiency (15-30 ng/mL) show no significant difference in risk of blood culture positivity relative to patients with vitamin D sufficiency.
DISCUSSION
The present study aimed to determine whether preadmission 25(OH)D was associated with all-cause mortality following ICU admission. This large 11-yr multicenter observational study illustrates the all-cause mortality risk of preadmission 25(OH)D deficiency. Preadmission 25(OH)D deficiency was a significant predictor of 30, 90, and 365 post-ICU day mortality as well as in-hospital mortality and remained a significant predictor of survival following multivariable adjustments for relevant comorbidities. In addition, our subset analysis suggests an increased sus-ceptibility to blood culture positivity in patients with vitamin D deficiency.
The mechanism for increased mortality following ICU admission in patients with hypovitaminosis D may be related to the pleiotropic functions of vitamin D. Vitamin D inhibits vascular smooth-muscle cell proliferation (24) , protects normal endothelial function (25) , and modulates inflammatory processes (26, 27) .
The primary effect of 1,25(OH) 2 D on the adaptive immune response is inhibitory, however effects on innate immune cells can be stimulatory. In vitamin D-deficiency, prior studies show defects in macrophage functions, such as phagocytosis, chemotaxis, and proinflammatory cytokine production (28) . Vitamin D is a key link between Toll-like receptor activation and antibacterial responses in innate immunity (29) . Toll-like receptor stimulation of human macrophages induces conversion of 25(OH)D to active 1,25(OH) 2 D, expression of the vitamin D receptor, and production of cathelicidin, a downstream target of the vitamin D receptor capable of promoting innate immunity (30 -32) .
Our data are consistent with an analysis of the National Health and Nutrition Examination Survey data in which low vitamin D levels were associated with an increased incidence of upper respiratory tract infections (33) . In another study, patients with severe vitamin D deficiency were abnormally susceptible to infections such as tuberculosis (34) and infection in general (35, 36) . Similarly, in a meta-analysis of 18 trials involving 57,311 randomly assigned subjects, Autier and Gandini (5) found that vitamin D supplementation reduced allcause mortality by 7% (confidence interval 1% to 13%). These observations and others suggest that hypovitaminosis D is likely to play a key role in infection and cardiac and metabolic dysfunctions in critically ill patients.
The present study has limitations. Selection bias may exist as the patient cohort under study had their vitamin D statuses investigated for a particular reason that may be absent in other patients treated with critical care. This is demonstrated by the significant differences in the total ICU population and the 25(OH)D cohort (Table  1 ). These noted differences may decrease the generalizability of our results to all critically ill patients. We cannot exclude the possibility that other unmeasured variables influence mortality independently of vitamin D, which may have biased estimates. Despite adjustment for multiple potential confounders, there may be residual confounding variables leading to observed differences in outcomes.
In a prior study of an outpatient population, the intraperson Pearson correlation coefficient for 25(OH)D is demonstrated to be 0.70 at 3 yrs between blood draws following adjustments for age, race, and season (37) . The majority of our cohort had 25(OH)D levels drawn 3 months before ICU admission. Our sensitivity analysis demonstrates preservation of the observed vitamin D-mortality association with Ͻ90 days between 25(OH)D level and ICU admission. Despite this observation, vitamin D levels at the time of critical care initiation are not available in this cohort and may have changed since preadmission values were determined. We do not have data available on over-thecounter supplementation or vitamin D prescribed by providers outside of clinics related to the hospitals under study. Such supplementation may have altered the true 25(OH)D-mortality association.
We define sepsis and comorbidity on the basis of administrative ICD-9-CM coding. Administrative coding has been evaluated for particular disease states (38 -42) and comorbidity profiles (43, 44) . The accuracy of ICD-9-CM coding for the identification of medical conditions remains controversial (19) . The several steps and participants required to assign ICD-9-CM codes introduce potential for error (45) . Despite these shortcomings, the ICD-9-CM code 038.x is reported to have a high positive predictive value for the identification of true cases of sepsis (46) and a high sensitivity (47) , specificity (19) , and negative predictive value (19) . Algorithms developed to recode ICD-9-CM-coded data into a Deyo-Charlson index are well studied, validated, and well suited for use in administrative data sets (48, 49) .
Our finding that preadmission 25(OH)D is a significant predictor of mortality does not include physiologic data. In the administrative database used in this study, temperature, blood pressure, heart rate, respiratory rate, and Glasgow Coma Scale data are not available, and thus, Acute Physiology and Chronic Health Evaluation scores are absent. Scoring systems inclusive of physiologic data including Acute Physiology and Chronic Health Evaluation are strong predictors of mortality in ICU patients (50) . Furthermore, it is not known if illness severity influences vitamin D levels at the time of ICU admission. It is possible that inclusion of a physiologic score in the analysis may materially alter the 25(OH)D-mortality association. With the addition of age and gender data, the Deyo-Charlson comorbidity index can be considered an alternative method of risk adjustment in the absence of physiologic data (51) . However, despite multivariable adjustment, the absence of physiologic data remains a limitation of our study. Finally, we are also unable to adjust for body mass index, immobilization, lack of sun exposure, and smoking status, factors that can alter 25(OH)D.
The present study has several strengths. As other chronic medical conditions may affect the attributed cause of death, allcause mortality is considered an unbiased and clinically relevant outcome in longterm observational studies (52, 53) . Utilization of the Social Security Death Index allows for long-term follow-up of the cohort following hospital discharge. Our study is a relatively large regional multicenter study with sufficient numbers of patients to ensure the adequate reliability of our mortality estimates (n ϭ 2399, hospital mortality rate of 15.6%). We employed previous records to define comorbidities that increase prevalence of these conditions, resulting in a better risk adjustment (40, 54) . Measurements of 25(OH)D before ICU admission allow for the inference of the potential importance of vitamin D sufficiency before the onset of critical illness.
In aggregate, these data demonstrate that preadmission 25(OH)D deficiency is strongly associated with the risk of death in critical illness and that this risk is independent of other risk factors. In addition, in patients with blood cultures drawn, 25(OH)D deficiency is strongly associated with the risk of blood culture positivity. In concert with the basic science evidence, we believe that these re- sults provide clinical evidence of a potential link between vitamin D and outcomes of critical illness. However, studies of this relationship in a cohort with uniform methods for the measurement of vitamin D and a uniform timing of measurement relative to the onset of critical illness are clearly warranted to further elucidate the role of vitamin D in critical illness. Positive findings in prospective studies may establish 25(OH)D as an important and modifiable risk factor for ICU mortality. Given the safety profile of vitamin D, positive results would provide strong motivation for examining the utility of activated vitamin D as a novel therapeutic agent designed to improve survival in critical illness. 8 The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002; 56:655-669 
